Elevance Health(ELV)
Search documents
Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research· 2024-01-24 13:11
Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.26%. A quarter ago, it was expected that this health insurer would post earnings of $8.45 per share when it actually produced earnings of $8.99, delivering a surprise of 6.39%.Over the last four quarters, the comp ...
Elevance Health Reports Results for Fourth Quarter and Full Year 2023; Sets Full Year 2024 Outlook
Businesswire· 2024-01-24 11:00
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2023 results. “We are pleased to have delivered another year of strong performance in 2023, enabled by our relentless focus on customer experience and affordability, and continued investments in growth and innovation. The balance and resilience of our business coupled with the focused execution of our enterprise strategy supports our confidence in our outlook for 2024, as we continue to optimize the found ...
Countdown to Elevance Health (ELV) Q4 Earnings: Wall Street Forecasts for Key Metrics
Zacks Investment Research· 2024-01-19 19:01
Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $5.55 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $41.82 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course o ...
Can Higher Costs Affect Elevance Health's (ELV) Q4 Earnings?
Zacks Investment Research· 2024-01-19 15:51
Elevance Health, Inc. (ELV) is set to report its fourth-quarter 2023 results on Jan 24, before the opening bell. This time around, the company’s overall earnings performance is likely to have received a boost from higher segmental profits, only to be undone by reduced total medical memberships and higher costs.What Do the Estimates Say?The Zacks Consensus Estimate for fourth-quarter earnings per share of $5.55 suggests a 6.1% increase from the prior-year figure of $5.23. The consensus mark remained stable o ...
ELV or HQY: Which Is the Better Value Stock Right Now?
Zacks Investment Research· 2024-01-17 17:46
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate re ...
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Zacks Investment Research· 2024-01-17 16:18
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Elevance Health (ELV) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Elevance Health is a member of the Medical sector. This group includes 1077 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank considers ...
Why You Should Retain Elevance (ELV) Stock in Your Portfolio
Zacks Investment Research· 2024-01-16 16:17
Elevance Health, Inc. (ELV) is positioned for growth with premium rate adjustments in the Health Benefits business, an expanding external pharmacy membership base and overall strength in the Carelon business. The BioPlus acquisition is expected to continue supporting the Carelon unit’s performance.Elevance — with a market cap of $111.6 billion — is one of the largest publicly traded health benefits companies in the United States. Courtesy of solid prospects, this currently Zacks Rank #3 (Hold) stock is wort ...
Why Elevance Health (ELV) is a Top Momentum Stock for the Long-Term
Zacks Investment Research· 2024-01-15 16:18
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?T ...
Elevance Health (ELV) Stock Drops Despite Market Gains: Important Facts to Note
Zacks Investment Research· 2024-01-13 00:33
The most recent trading session ended with Elevance Health (ELV) standing at $475.12, reflecting a -1.49% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.08%. Elsewhere, the Dow saw a downswing of 0.31%, while the tech-heavy Nasdaq appreciated by 0.02%.The the stock of health insurer has risen by 0.51% in the past month, lagging the Medical sector's gain of 6.57% and the S&P 500's gain of 3.52%.Analysts and investors alike will be keeping a close eye on the per ...
Here's Why Elevance Health (ELV) is a Strong Value Stock
Zacks Investment Research· 2024-01-12 16:19
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...